NEW YORK--(BUSINESS WIRE)--JOGO Health (JOGO), a medtech company treating chronic pain and neuromuscular disorders, announced it has closed over $5.5 million in an investment round led by Hourglass Ventures. Due to high demand, the company is opening the round to public retail investors via a Regulation CF community investment round on Wefunder, inviting retail investors to join alongside firms like Mayo Clinic Ventures, the venture arm of the world-renowned hospital..

纽约——（商业新闻短讯）——JOGO Health（JOGO）是一家治疗慢性疼痛和神经肌肉疾病的医疗技术公司，它宣布在沙漏风险投资公司（Hourglass Ventures）领导的一轮投资中，已关闭550多万美元。由于需求旺盛，该公司将通过Wefunder上的社区投资回合（Regulation CF community investment round）向公众散户投资者开放这一回合，邀请散户投资者与梅奥诊所风险投资公司（Mayo Clinic Ventures）等公司一道加入，梅奥诊所风险投资公司是世界知名医院的风险投资子公司。。

JOGO's wearable technology and app leverage the brain's natural neuroplasticity to provide non-invasive, drug-free relief for conditions including chronic lower back pain, stroke recovery, migraines, and incontinence. Cleared by the FDA and reimbursed by Medicare and commercial insurance, JOGO is expanding a $380B market without drugs or surgery, supported by 18 patent claims across all neuromuscular conditions.

JOGO的可穿戴技术和应用程序利用大脑的天然神经可塑性，为慢性腰痛、中风恢复、偏头痛和尿失禁等疾病提供无创、无药物的缓解。JOGO获得了FDA的批准，并得到了医疗保险和商业保险的报销，它正在扩大一个3800亿美元的市场，不需要药物或手术，所有神经肌肉疾病都有18项专利申请支持。

JOGO has already treated 25,000+ patients across 50+ hospital channel partners, including Mayo Clinic, Mount Sinai Hospital, and Brigham and Women's Hospital..

JOGO已经在50多家医院渠道合作伙伴中治疗了25000多名患者，其中包括梅奥诊所、西奈山医院和布莱根妇女医院。。

Led by a team of accomplished healthcare entrepreneurs, JOGO’s team brings experience from Columbia University, Harvard University, Yale University, AT&T, Johnson & Johnson, and Astrazeneca. Co-Founder and CEO Sanjai Murali built JOGO from zero to FDA market authorization. Siva Nadarajah, President and Co-Founder, previously sold an AI healthcare startup to leading clinical research company IQVIA, delivering a 10x return to investors..

JOGO的团队由一群有成就的医疗保健企业家领导，拥有哥伦比亚大学、哈佛大学、耶鲁大学、美国电话电报公司、强生公司和阿斯利康公司的经验。联合创始人兼首席执行官桑贾伊·穆拉里（SanjaiMurali）将JOGO从零发展到FDA市场授权。总裁兼联合创始人Siva Nadarajah之前将一家AI医疗保健初创公司出售给领先的临床研究公司IQVIA，为投资者带来了10倍的回报。。

'The conviction of our investors is phenomenal,' added Siva Nadarajah, President and Co-Founder. 'This round will enable us to meet growing demand.”

总裁兼联合创始人西瓦·纳达拉亚（SivaNadarajah）补充说，我们投资者的信念是惊人的这一轮将使我们能够满足不断增长的需求。”

'We believe healthcare is too important to be controlled by a few,' said Sanjai Murali, CEO and Co-Founder. “JOGO is founded on the vision of 'by the world, for the world,' and opening our investment round to retail investors on Wefunder is a crucial step towards realizing this vision.'

首席执行官兼联合创始人桑贾伊·穆拉里（SanjaiMurali）说，我们认为医疗保健太重要了，不能被少数人控制。“JOGO建立在‘由世界，为世界’的愿景之上，向Wefunder的散户投资者开放我们的投资回合是实现这一愿景的关键一步。”

Capital raised will support JOGO’s commercial launch, putting JOGO on track to become the first line of treatment for chronic pain and other neuromuscular disorders - impacting 1 in 5 people globally. The community investment round is open to everyone via Wefunder, with a minimum investment of $100..

筹集的资金将支持JOGO的商业启动，使JOGO有望成为治疗慢性疼痛和其他神经肌肉疾病的一线药物，影响全球五分之一的人。社区投资回合通过Wefunder向所有人开放，最低投资额为100美元。。

For more information about JOGO Health and to invest, visit wefunder.com/jogohealth.

有关JOGO Health的更多信息和投资，请访问wefunder.com/jogohealth。

About JOGO Health:

关于GAME Health：

JOGO Health is a medtech company treating chronic pain and neuromuscular disorders, including stroke, migraines, and incontinence. Cleared by the FDA and reimbursed by Medicare and commercial insurance, JOGO’s wearable technology and app leverage the brain’s natural neuroplasticity to offer relief from pain and aid recovery from neuromuscular conditions, expanding a $380B market without drugs or surgery.

JOGO Health是一家治疗慢性疼痛和神经肌肉疾病（包括中风、偏头痛和尿失禁）的医疗技术公司。JOGO的可穿戴技术和应用程序得到了FDA的批准，并得到了医疗保险和商业保险的报销，它利用大脑的天然神经可塑性来缓解疼痛，帮助神经肌肉疾病的恢复，在不使用药物或手术的情况下扩大了3800亿美元的市场。

JOGO has already treated 25,000+ patients and completed 100,000+ sessions across 50+ hospital partners, including Mayo Clinic and Mount Sinai. The company is backed by leading investors Mayo Clinic Ventures and Hourglass Ventures. For more information, please visit jogohealth.com..

JOGO已经治疗了25000多名患者，并在包括梅奥诊所和西奈山在内的50多家医院合作伙伴中完成了100000多次治疗。该公司得到了领先投资者梅奥诊所风险投资公司和沙漏风险投资公司的支持。有关更多信息，请访问jogohealth.com。。